Trial Profile

A Feasibility Study to Evaluate the Effect of Ustekinumab on Systemic and Vascular Inflammation Associated with Metabolic Syndrome and Cardiovascular Disease in Patients with Moderate to Severe Psoriasis using 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography [18F-FDG PET/CT]

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 27 Mar 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

17 Mar 2018 According to results published in the Journal of the American Academy of Dermatology, patients and healthy individuals were referred and screened for the study between Mar 2013 and Feb 2015.
17 Mar 2018 Results published in the Journal of the American Academy of Dermatology.
08 Jun 2017 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com